Thomas Ciulla
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Thomas Ciulla
Viridian Therapeutics, Inc.\DE reported in an 8-K filed January 8, 2024 that Thomas Ciulla was appointed Chief Medical Officer, effective January 3, 2024.
“The Board of Directors of the Company appointed Dr. Thomas Ciulla, formerly the Company’s Chief Development Officer since February 2023, as Chief Medical Officer of the Company effective January 3, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-03–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Viridian Therapeutics, Inc.\DE
Other people whose current roles at this company are on record from its filings.
- Scott Myers CEO, Board Member
- Stephen Mahoney CEO, Board Member
- Tomas Kiselak Chairman
- Seth Harmon CFO
- Jonathan Violin COO
- Lee Rauch COO, Board Member
- Thomas Beetham COO
- Lara Meisner General Counsel
- Kristian Humer Chief Accounting Officer
- Arlene M. Morris Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.